New and emerging treatment options for multiple sclerosis-Reference-Cited by-同舟云学术

New and emerging treatment options for multiple sclerosis

Published:2003-09 Issue:9 Volume:2 Page:563-566
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Polman Chris H,Uitdehaag Bernard MJ

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference31 articles.

1. Interferons in relapsing remitting multiple sclerosis: a systematic review;Filippini;Lancet,2003

2. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis;Lancet,1998

3. North American study group on interferon beta-1b in secondary progressive MS. Interferon beta-1b in secondary progressive MS: clinical and MRI results of a 3-year randomized controlled trial;Goodkin;Neurology,2000

4. Randomized controlled trial of interferon beta-1a in secondary progressive MS: clinical results;Neurology,2001

5. Benefit of interferon beta-1a on MSFC progression in secondary progressive MS;Cohen;Neurology,2002

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Assessment of Brain Disorders;Machine Learning for Brain Disorders;2023

2. Applied picture fuzzy sets with knowledge reasoning and linguistics in clinical decision support system;Neuroscience Informatics;2022-12

3. Caspase-11 Noncanonical Inflammasome: A Novel Key Player in Murine Models of Neuroinflammation and Multiple Sclerosis;Neuroimmunomodulation;2021

4. Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis;Frontiers in Immunology;2019-03-22

5. Specific Single Chain Antibodies Against A Neuronal Growth Inhibitor Receptor, Nogo Receptor 1: Promising New Antibodies for the Immunotherapy of Multiple Sclerosis;Shiraz E-Medical Journal;2017-01-21